| 51 |
26389772 | An update of the blockade of the renin angiotensin aldosterone system in clinical practice. | 2015 |
1 |
| 52 |
26464664 | KRT6 interacting with notch1 contributes to progression of renal cell carcinoma, and aliskiren inhibits renal carcinoma cell lines proliferation in vitro. | 2015 |
1 |
| 53 |
26501147 | Comparative Effect of a Renin Inhibitor and a Thiazide Diuretic on Renal Tissue Oxygenation in Hypertensive Patients. | 2015 |
1 |
| 54 |
23396551 | Effects of antihypertensive therapy on glucose, insulin metabolism, left ventricular diastolic dysfunction and renin system in overweight and obese hypertensives. | 2014 Jun |
1 |
| 55 |
23665882 | Direct renin inhibitor induced renal failure. | 2014 Mar-Apr |
1 |
| 56 |
24038019 | Renin-angiotensin system blocking drugs. | 2014 Jan |
1 |
| 57 |
24152824 | Renin-sensitive microRNAs correlate with atherosclerosis plaque progression. | 2014 Apr |
1 |
| 58 |
24154707 | Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading. | 2014 Aug |
1 |
| 59 |
24253615 | Effect of aliskiren in chronic kidney disease patients with refractory hypertension undergoing hemodialysis: a randomized controlled multicenter study. | 2014 Oct |
1 |
| 60 |
24304656 | Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy. | 2014 Feb |
1 |
| 61 |
24337365 | Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases. | 2014 Nov |
1 |
| 62 |
24433061 | Effects of aliskiren on blood pressure and humoral factors in hypertensive hemodialysis patients previously on angiotensin II receptor antagonists. | 2014 |
1 |
| 63 |
24470465 | Multiple ascending dose study with the new renin inhibitor VTP-27999: nephrocentric consequences of too much renin inhibition. | 2014 May |
1 |
| 64 |
24517108 | Efficacy and safety profile of aliskiren: practical implications for clinicians. | 2014 |
1 |
| 65 |
24637873 | Renin inhibitor VTP-27999 differs from aliskiren: focus on their intracellular accumulation and the (pro)renin receptor. | 2014 Jun |
1 |
| 66 |
24694816 | [Influence of temperature and humidity on physico-pharmaceutical characteristics of Rasilez(®) tablets]. | 2014 |
2 |
| 67 |
24739274 | Liquid chromatography-tandem mass spectrometry method for determination of aliskiren in saliva and its application to a clinical trial with healthy volunteers. | 2014 Aug 5 |
1 |
| 68 |
24788577 | Simultaneous quantitative and qualitative analysis of aliskiren, enalapril and its active metabolite enalaprilat in undiluted human urine utilizing LC-ESI-MS/MS. | 2014 Dec |
1 |
| 69 |
25039889 | Effect of add-on aliskiren to type 1 angiotensin receptor blocker therapy on endothelial function and autonomic nervous system in hypertensive patients with ischemic heart disease. | 2014 Aug |
1 |
| 70 |
26417326 | Renin inhibitors in diabetes and hypertension: an update. | 2014 |
3 |
| 71 |
22045153 | Effects of aliskiren on the fibrinolytic system in patients with coronary artery disease receiving angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor blocker. | 2013 Jan |
1 |
| 72 |
22392185 | Renin inhibitors and cardiovascular and renal protection: an endless quest? | 2013 Apr |
1 |
| 73 |
22618635 | Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease. | 2013 Jul |
1 |
| 74 |
22791702 | Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats. | 2013 Mar |
1 |
| 75 |
22827288 | The effects of direct renin inhibitor, aliskiren, on arterial hypertension, chronic kidney disease and cardiovascular disease: optimal pharmacotherapy. | 2013 Mar |
1 |
| 76 |
22834767 | Direct renin inhibition improves parasympathetic function in diabetes. | 2013 Jan |
1 |
| 77 |
23055424 | Determination of aliskiren in human serum quantities by HPLC-tandem mass spectrometry appropriate for pediatric trials. | 2013 Apr |
1 |
| 78 |
23132848 | Efficacy of aliskiren and valsartan in hypertensive patients with albuminuria: a randomized parallel-group study. | 2013 Dec |
1 |
| 79 |
23278708 | Direct renin inhibition in chronic kidney disease. | 2013 Oct |
2 |
| 80 |
23418282 | Hypotension and ischaemic stroke associated with aliskiren in the ALTITUDE trial: sensitisation of the Bezold-Jarisch reflex? | 2013 Mar |
1 |
| 81 |
23475471 | It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia. | 2013 May-Jun |
1 |
| 82 |
23478743 | Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. | 2013 Mar 20 |
1 |
| 83 |
23487045 | Direct renin inhibition: extricating facts from façades. | 2013 Jun |
1 |
| 84 |
23509108 | Inhibition of the renin-angiotensin system reduces the rise in serum aldosterone in acute coronary syndrome patients with preserved left ventricular function: observations from the AVANT GARDE-TIMI 43 trial. | 2013 Jun |
1 |
| 85 |
23541666 | No increase in adverse events during aliskiren use among ontario patients receiving angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers. | 2013 May |
1 |
| 86 |
23557551 | Effect of aliskiren on arterial stiffness, compared with ramipril in patients with mild to moderate essential hypertension. | 2013 Apr |
2 |
| 87 |
23577328 | Direct Renin inhibitor: aliskiren in chronic kidney disease. | 2013 Winter |
1 |
| 88 |
23615219 | Renin inhibition with aliskiren lowers circulating endothelial progenitor cells in patients with early atherosclerosis. | 2013 Mar |
1 |
| 89 |
23615633 | Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease. | 2013 |
3 |
| 90 |
23649371 | Liquid chromatography-tandem mass spectrometric assay for aliskiren, a novel renin inhibitor in micro-volumes of human plasma: a pharmacokinetic application in healthy South Indian male subjects. | 2013 Aug |
1 |
| 91 |
23676368 | Effectiveness of the direct renin inhibitor, aliskiren, in patients with resistant hypertension. | 2013 |
1 |
| 92 |
23686372 | Aliskiren effect on plaque progression in established atherosclerosis using high resolution 3D MRI (ALPINE): a double-blind placebo-controlled trial. | 2013 May 17 |
1 |
| 93 |
23695772 | Effects of direct renin inhibition on atherosclerotic biomarkers in patients with stable coronary artery disease and type 2 diabetes mellitus. | 2013 Sep |
1 |
| 94 |
23723254 | Use of aliskiren in Latin America in a real-world setting: aliskiren in Latin America Study (ALAS). | 2013 Aug |
1 |
| 95 |
23736778 | Aliskiren, a direct renin inhibitor, improves vascular endothelial function in patients on hemodialysis independent of antihypertensive effect ∼ a pilot study∼. | 2013 |
3 |
| 96 |
23743807 | Urinary renin and angiotensinogen in type 2 diabetes: added value beyond urinary albumin? | 2013 Aug |
1 |
| 97 |
23756824 | Direct renin inhibition--a promising strategy for renal protection? | 2013 Jun 12 |
1 |
| 98 |
23873285 | Review of direct renin inhibition by aliskiren. | 2013 Sep |
1 |
| 99 |
23926182 | The direct renin inhibitor aliskiren localizes and persists in rat kidneys. | 2013 Dec 1 |
1 |
| 100 |
23997927 | Aliskiren: review of efficacy and safety data with focus on past and recent clinical trials. | 2013 Sep |
2 |